FAST: new look at the febuxostat safety profile

被引：10
作者：
Bardin, Thomas [1 ,2 ,3 ]
Richette, Pascal [1 ,2 ]
机构：
[1] Hop Lariboisibre, APHP Paris Nord, Dept Rheumatol, F-75010 Paris, France
[2] Univ Paris, INSERM, UMR1132, Bioscar, F-75010 Paris, France
[3] Vien Gut Med Ctr, French Vietnamese Res Ctr Gout & Chron Dis, Ho Chi Minh City, Vietnam
来源：
LANCET | 2020年 / 396卷 / 10264期
关键词：
D O I：
10.1016/S0140-6736(20)32343-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1704 / 1705
页数：2
相关论文
共 5 条
  • [1] The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
    Becker, Michael A.
    Schumacher, H. Ralph
    Espinoza, Luis R.
    Wells, Alvin F.
    MacDonald, Patricia
    Lloyd, Eric
    Lademacher, Christopher
    [J]. ARTHRITIS RESEARCH & THERAPY, 2010, 12 (02)
  • [2] Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial
    Mackenzie, Isla S.
    Ford, Ian
    Nuki, George
    Hallas, Jesper
    Hawkey, Christopher J.
    Webster, John
    Ralston, Stuart H.
    Walters, Matthew
    Robertson, Michele
    De Caterina, Raffaele
    Findlay, Evelyn
    Perez-Ruiz, Fernando
    McMurray, John J. V.
    MacDonald, Thomas M.
    [J]. LANCET, 2020, 396 (10264) : 1745 - 1757
  • [3] Failure to reach uric acid target of <0.36 mmol/L in hyperuricaemia of gout is associated with elevated total and cardiovascular mortality
    Perez Ruiz, Fernando
    Richette, Pascal
    Stack, Austin G.
    Gurunath, Ravichandra Karra
    Garcia de Yebenes, Ma Jesus
    Carmona, Loreto
    [J]. RMD OPEN, 2019, 5 (02):
  • [4] US Food and Drug Administration, 2019, FDA ADDS BOX WARN IN
  • [5] Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
    White, William B.
    Saag, Kenneth G.
    Becker, Michael A.
    Borer, Jeffrey S.
    Gorelick, Philip B.
    Whelton, Andrew
    Hunt, Barbara
    Castillo, Majin
    Gunawardhana, Lhanoo
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (13) : 1200 - 1210
1